Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Konini A, Kang M, Moghadas SM, Simulating immune interferences on the effect of a bivalent glycoconjugate vaccine against Haemophilus influenzae serotypes ‘a’ and ‘b’, Canadian Journal of Infectious Diseases and Medical Microbiology 2016, 5486869.
Konini A, Nix E, Ulanova M, Moghadas SM, Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population, Preventive Medicine Reports 2016, 3: 145–150.
Laskowski M, Xiao Y, Charlend N, Moghadas SM, Strategies for early vaccination during novel influenza outbreaks, Scientific Reports 2015, 5: 18062.
Knipl D, Moghadas SM, The potential impact of vaccination on the dynamics of dengue infection, Bulletin of Mathematical Biology 2015, 77: 2212-2230.
Moghadas SM, Haworth-Brockman M, Isfeld-Keily H, Kettner J, Improving public health policy through infection transmission modelling: guidelines for creating a community of practice, Canadian Journal of Infectious Diseases and Medical Microbiology 2015, 26: 191-195.
Konini A, Moghadas SM, Modelling the impact of vaccination on curtailing Haemophilus influenzae serotype ‘a’, Journal of Theoretical Biology 2015, 387, 101-110.
Xiao Y, Moghadas SM, The impact of ethnicity and geographic location of residence on the 2009 influenza H1N1 pandemic vaccination, Epidemiology and Infection 2015, 143: 757-765.
Laskowski M, Greer AL, Moghadas SM, Antiviral strategies for emerging influenza viruses in remote communities, PLoS One 2014, 9(2): e89651.
Jaberi–Douraki M, Moghadas SM, Optimal control of vaccination dynamics during an influenza epidemic, Mathematical Biosciences and Engineering 2014, 11: 1045-1063.
Driedger SM, Cooper E, Moghadas SM, Developing model–based public health policy through knowledge translation: the need for a “Communities of Practice”, Public Health 2014, 128: 561-567.